Numbness and Peripheral Neuropathy — The Long Supply Line That Runs Short at the Farthest Village, the Sock That Climbs From the Toes

"My Toes Are Tingling"

A fifty-eight-year-old office worker says that for a few months now, whenever they lie down to sleep, both toe tips tingle and prickle. During the day, the soles of their feet feel numb, as if wearing an extra layer of socks, and they cannot quite tell with their feet how hot the bathwater is. At the hospital, they were told that the nerves going to the feet have been damaged.

The single word "tingling" is not enough to tell us what is causing it. This article starts from what the word tingling holds, and looks in turn at why nerve disease rising from the toes occurs, tests and treatments, and the signals that must be checked promptly.

The Many Meanings of Numbness

When people say their fingertips or toes feel numb, they pack several different sensations into a single word. Dullness, tingling, a sharp pinprick sensation, and reduced feeling all fall under the umbrella of numbness (PMID 37921132). Paresthesia is the feeling of tingling or prickling when nothing is actually touching the skin. Hypesthesia is a state where touch or pain is felt less acutely than before. The sensation can also present as a burning, fiery pain in the soles of the feet, which is commonly seen when thin nerve fibers are damaged, as we will explore later (PMID 39580213).

Numbness can also originate in several different places. Sensory nerves are nerves that carry information from the skin, muscles, and joints up toward the spinal cord and the brain. Because numbness in the hands and feet can arise when anything goes wrong anywhere along this sensory pathway, the root cause can span anywhere from the nerves in the limbs all the way to the brain (PMID 37921132). Peripheral nerves are the nerves that branch out from the brain and spinal cord, extending into the limbs and throughout the body.

Even if the very beginning of a peripheral nerve branching off from the spinal cord—namely, the nerve root—is compressed in the lower back or neck, numbness can occur. Radiculopathy is a condition where a nerve root is compressed or injured, leading to pain, numbness, and weakness along the area supplied by that root.

This is why doctors in the clinic look closely at the pattern of the numbness. Whether it came on suddenly or has lasted a long time, whether it is symmetrical on both sides or concentrated on one side, whether only sensation has changed or muscle weakness is also present, and whether symptoms related to internal bodily functions like sweating or blood pressure stand out are all clues that narrow down the cause (PMID 31639835). The most common cause of numbness in the hands and feet is a single nerve being compressed at one location, most often at the wrist, while symmetrical numbness in both hands and feet is a hallmark of diseases that damage multiple nerves at once (PMID 37921132).

Numbness is a word that bundles together several different sensations, and knowing where it started, whether it affects both sides, and how quickly it arrived helps narrow down its source.

From the Farthest End

Let us return to the numbness that started together in both tips of the feet, like the office worker at the beginning. Peripheral neuropathy is a disease caused by injury to peripheral nerves. Roughly 1% of adults worldwide suffer from it, the causes number over 200, and the symptoms range widely from mild toe numbness to ones severe enough to require a wheelchair (PMID 41247746). Polyneuropathy is a peripheral neuropathy in which multiple peripheral nerves are injured all at once, usually symmetrically on both sides.

A nerve cell is the basic cell of the brain and nerves that receives electrical signals and passes them on to the next cell. An axon is a branch that stretches long from the body of a nerve cell and sends signals toward the next cell. A single strand of peripheral nerve is a bundle of countless such axons. Among them, the axon going down to the toe is the longest in the body (PMID 41247746).

Length dependence is the property where symptoms appear first at the tip of the longest axon and climb upward toward the body over time. Peripheral neuropathy is usually length-dependent, so it starts in the toes and climbs toward the body, is usually symmetrical on both sides, and axons responsible for sensation are injured more than those responsible for movement (PMID 41247746). When a similar pattern appears on the hands as well, it traces the areas where socks and gloves would be worn, so it is called the "stocking-and-glove" pattern (PMID 36786097).

Let us think of a supply route stretching long from headquarters to a distant village. The body of the nerve cell is headquarters, and the axon is the road extending from that headquarters to the final village. For an axon to stay alive all the way to the end, supplies must reach the end of the road, and the longer the road, the harder that task is. When supplies begin to run short, the farthest village cannot hold out first, and the places where supplies fall short gradually creep closer to headquarters. The farthest village is the toe. Diabetes is a disease in which the state of blood sugar being higher than the normal range continues for a long time. In neuropathy caused by diabetes, the reason is found in the collapse of the energy supply of the long-stretched axon and the cells supporting its side (PMID 37263266).

The analogy holds true up to this point. What is carried along the supply route are the supplies necessary for the axon to stay alive, and nerve signals travel back and forth separately. Sensation signals from the toe actually travel upward from the toe toward the spinal cord, and the way signals are transmitted along the axon was covered in "How Do Nerve Cells Send Signals? — A Burning Fuse, a Gap Crossed by Ferry". The explanation given for why the end village runs short first was put forth with regard to neuropathy caused by diabetes, so it cannot be transferred as-is to all causes.

Besides the pathways for sensation and movement, peripheral nerves also contain pathways that handle organs inside the body. The autonomic nervous system is the nervous system that regulates organs we cannot move at will, such as the heart, blood vessels, intestines, and glands.

Axons also vary in thickness. Large fibers are thick axons wrapped in thick sheaths, and they carry signals quickly. The sense of touch and vibration, the sense of knowing the position of arms and legs even with eyes closed, and movement instructions going to muscles mainly travel this path. Small fibers are thin axons with thin sheaths or none at all, and they carry pain and temperature sensations and autonomic nerve signals. When small fibers are injured, the senses for pain and temperature change, and autonomic functions also malfunction (PMID 40002491).

Depending on whether large fibers or small fibers are mainly injured, autonomic symptoms or weakness may accompany or follow (PMID 36997315).

Peripheral neuropathy usually starts bilaterally at the tips of the toes—the ends of the longest axons—and climbs toward the body.

What Damages Nerves

The most common cause of peripheral neuropathy is diabetes (PMID 41247746). Diabetic neuropathy is a condition where diabetes damages the nerves that branch out to all parts of the body. This condition is estimated to affect roughly 206 million people worldwide, and accounts for over half of all peripheral neuropathy cases in Western populations (PMID 41247746).

The proportion of people with diabetes who also have neuropathy varies depending on the data source. An analysis pooling 29 studies and 50,112 participants found the rate to be 30%, with 31.5% in type 2 diabetes (PMID 37263266)—which makes up the vast majority of diabetes cases—and 17.5% in type 1 (PMID 31917119). Another review noted that 10% to 15% of people newly diagnosed with type 2 diabetes already have it, and that number can exceed 50% in people who have had diabetes for more than 10 years. The longer a person has lived with diabetes, the higher the proportion becomes (PMID 38264279).

Next is vitamins. Vitamin B12 deficiency is a state in which the body lacks the vitamin B12 needed to build nerves and blood cells. Roughly 2% to 3% of US adults have this deficiency, and risk factors include conditions that impair absorption, eating less of it in food, certain medications, and older age. When a deficiency is confirmed, it is filled by supplementation (PMID 40961307). Reduced vitamin B12 absorption was commonly seen in people taking certain diabetes medications, leading to deficiency (PMID 38034222). Decisions about tests and medications are made with the prescribing physician.

Having peripheral neuropathy was linked to low vitamin B12 levels in the blood, but an analysis pooling four trials showed no clear link between vitamin B12 treatment and symptom improvement. The authors viewed the results as suggesting that vitamin B groups might help alleviate symptoms, but noted that the trials had limitations and mostly did not check whether participants actually lacked vitamins before treatment (PMID 33619867). Therefore, it remains unsettled whether supplementation helps people who do not have a deficiency. Vitamin B6 is linked to neuropathy when it is in excess rather than when it is lacking (PMID 41609902).

Alcohol and chemotherapy drugs also damage nerves. Confirmed peripheral neuropathy through testing was found in 46.3% of people who had been heavy drinkers for a long time, with the total lifetime amount of alcohol consumed being the biggest risk factor; whether this is due to the toxicity of alcohol itself or other factors is not yet known (PMID 30467601).

Chemotherapy-induced neuropathy is a peripheral neuropathy that occurs when certain chemotherapy drugs damage peripheral nerves. Symptoms are typically sensory rather than motor, leading to reduced sensation or hypersensitivity to pressure, pain, temperature, and touch (PMID 35104697). In an analysis pooling 31 studies and 4,179 patients, the condition remained in 68.1% of patients during the first month after chemotherapy ended, 60.0% at 3 months, and 30.0% at 6 months or later (PMID 25261162). The 2020 guidelines from the American Society of Clinical Oncology (ASCO) reaffirmed that there are no drugs to recommend for preventing this neuropathy, and recommend that if unbearable neuropathy or functional impairment occurs, medical staff should evaluate whether it is appropriate to delay, reduce, switch, or stop the chemotherapy drug (PMID 32663120).

Other causes include innate genetics, certain medications, and a condition in which a single type of antibody protein in the blood increases abnormally (PMID 41247746). Furthermore, up to 27% of adults with neuropathy cannot find a cause even after going through testing (PMID 41247746). Looking solely at polyneuropathy that starts from the tips of the toes and centers on sensation, about half initially remain of unknown origin even after thorough evaluation. A significant portion of those later reveal a cause as new symptoms appear or testing advances (PMID 36997315). This is why numbness ascending symmetrically from the tips of the toes should not simply be dismissed as a sign of aging, but rather investigated for a cause through physical examinations and blood tests.

The most common cause of peripheral neuropathy is diabetes, but there are over 200 causes, and vitamin supplementation clearly has a place when a deficiency is confirmed.

Physical Examination and Nerve Conduction Studies

The clinic where nerves are evaluated begins with questions. Doctors ask when and where the symptoms started, whether anyone in the family has something similar, and what kind of work the patient does, followed by a neurological examination and a general physical examination (PMID 31639835).

A nerve conduction study applies mild electrical stimulation to a nerve through the skin and measures how fast and large the signal travels. An electromyography is an examination that inserts a thin needle electrode into a muscle to read the electrical signals produced by the muscle. Electromyography is used to distinguish whether weakness is due to a nerve disease or a muscle disease (PMID 10653302). Both tests are the primary tools for investigating polyneuropathy with damaged large fibers, distinguishing whether the axon itself is damaged or the myelin sheath is primarily damaged. If the results lean toward primary damage to the myelin sheath, the suspected causes narrow significantly, and the likelihood of finding a treatable cause increases (PMID 31639835).

This testing has clear limitations. Nerve conduction studies measure only thick fibers with thick myelin sheaths (PMID 10653302). Therefore, in neuropathies where only small fibers are damaged, standard tests that look at large fibers come back normal (PMID 40002491). Small fiber neuropathy is diagnosed with a test that takes a small skin biopsy to count nerve fibers inside the skin and a test that measures how well a person perceives temperature or pain stimuli, and those results must match the symptoms and examination findings (PMID 40002491).

Test results are always read together with examination findings, and even if an abnormality appears on a test, it is rare for a single disease to be determined by that alone (PMID 10653302).

Blood tests are also performed together. The initially recommended blood tests are tests to check blood sugar to find diabetes, vitamin B12 and its metabolites, and abnormal antibody proteins in the blood (PMID 41247746). Because treatable causes are increasing, finding the cause is important and often time-sensitive (PMID 31639835).

Because nerve conduction studies look only at large fibers, they can come back normal in neuropathies where only thin fibers are damaged.

When One Spot Is Pressed

Some people wake up at night with numb hands and must shake them to fall back asleep. Waking up with pain, numbness, and dulled sensation is the classic symptom of carpal tunnel syndrome (PMID 18269111). Carpal tunnel syndrome is a condition caused by compression of a nerve passing through the carpal tunnel, a narrow passage in the wrist. It is the most common condition caused by a single nerve being compressed in a narrow passageway (PMID 38697747).

Numbness and pain occur in the area served by this nerve. It affects the palm side of the thumb, index finger, middle finger, and the thumb-side half of the ring finger (PMID 28075090). New cases are reported at a rate of 1 to 3 per 1,000 people, it is common between ages 45 and 60, and it is more frequent in women (PMID 32323256). Being female, obesity, work-related factors, and bodily states such as hypothyroidism or pregnancy are cited as risk factors (PMID 38697747). Because numbness is concentrated in the territory served by a single nerve, its pattern differs from polyneuropathy, which ascends from both tips of the feet.

Diagnosis is made through symptoms and physical examination, and nerve conduction studies support the diagnosis, though some patients test normal (PMID 38697747). They are also used to distinguish other causes that make the same hand feel numb, such as compression of a nerve root in the neck or polyneuropathy (PMID 32323256).

There are also physical exams that try to trigger numbness by bending the wrist or tapping over the nerve site. In actual patients with this condition, the proportion who tested positive was about 57% for the wrist-bending test and about 45% for the tapping test. The proportion of people without the disease who tested negative was about 67% and 78%, respectively. The authors stated that this pooled analysis is imprecise and concluded that one should not rely on any single hand maneuver but use multiple tests together (PMID 37366626).

Treatment varies depending on severity. A 2016 review noted that for mild or moderate cases, treatment can begin with conservative care such as wrist splints, steroids, and physical therapy. Nonsteroidal anti-inflammatory drugs, diuretics, and vitamin B6 were ineffective, while steroid injections into the wrist relieved symptoms for over a month and delayed the time when surgery became necessary up to a year later. It recommended that for severe cases, or when there is no improvement after 4 to 6 months of conservative care, surgery to widen the compressed passage should be advised (PMID 28075090).

Carpal tunnel syndrome is a condition where a single nerve is compressed in the wrist, causing numbness in the thumb and index finger sides, and it typically worsens at night.

Causes, Pain, and the Feet

Complete recovery after a nerve is damaged is rare, even when the underlying cause is treatable. The prognosis varies depending on the cause (PMID 41247746). Much like a supply route, refilling a destination village that has already emptied out is no simple task. Treatment therefore branches into three paths: addressing the cause to prevent further depletion, easing the pain, and protecting the foot where sensation has grown dull.

Addressing the cause differs for each origin. For neuropathies caused by inflammation, such as the condition where the immune system attacks nerves that we will examine later, effective immune treatments exist, while other neuropathies aim to manage the underlying cause to halt or slow progression (PMID 32837227). A 2022 review noted that in type 1 diabetes, tight blood sugar control prevents neuropathy from developing, whereas in type 2, the benefit of preventing neuropathy is small or nonexistent. It suggested that this is likely because type 2 is often accompanied by other conditions, highlighting metabolic syndrome—a cluster of problems involving obesity, blood pressure, and fats in the blood—as a major risk factor. Management is tailored to simultaneously address diabetes, metabolic syndrome, and pain (PMID 36115364). For neuropathy caused by diabetes, no treatment has yet been widely recognized as modifying the disease's actual progression (PMID 34050323). A 2014 review noted that diabetic neuropathy cases where only small fibers are damaged or that are in a pre-symptomatic stage can be reversed or significantly improved with appropriate management (PMID 25299279). If vitamin B12 deficiency is the cause, it is replenished through supplementation (PMID 40961307), and if caused by chemotherapy, the medical team weighs whether to adjust the chemotherapy drugs (PMID 32663120).

Pain calls for dedicated medications. Neuropathic pain is pain caused by injury or disease within the sensory nervous system itself. It frequently arrives as a burning, stabbing, tingling, or electric shock-like sensation (PMID 40572751). The Neuropathic Pain Special Interest Group (NeuPSIG) of the International Association for the Study of Pain strongly recommended three drug classes as first-line treatments in 2025: tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, and the alpha-2-delta ligand drug class, which binds to a part of the nerve's calcium channels (PMID 40252663).

The magnitude of an effect is viewed through numbers compared against a dummy pill. A placebo is a dummy pill that looks identical but contains no active medical ingredient. The number needed to treat represents how many people must take a drug for one additional person to experience a benefit compared to taking a placebo instead. In an analysis pooling 313 randomized trials (trials treating or observing for three weeks or longer) covering neuropathic pain from various causes and involving 48,789 adults, when effectiveness was counted as people reporting their pain reduced by 30%, by more than half, or quite a bit, the numbers needed to treat were 4.6 for tricyclic antidepressants, 7.4 for serotonin-norepinephrine reuptake inhibitors, and 8.9 for the alpha-2-delta ligand drug class. The numbers needed to cause one additional person to quit the drug due to side effects were 17.1, 13.9, and 26.2, respectively. The authors concluded that the treatment outcomes are modest and uncertainties remain for some treatments, adding that larger trials over clinically meaningful durations are further needed (PMID 40252663).

Compared to a placebo, this means that for every five to nearly nine people who take the medication, one additional person benefits, while for every fourteen to twenty-six people who take it, one additional person also stops the drug due to side effects. An earlier 2015 analysis (229 trials) estimated that publication bias may have inflated treatment effects by about 10% (PMID 25575710). Pain frequently remains even after using medication, and combining multiple drugs can add further benefits (PMID 41247746). For pain from chemotherapy-induced neuropathy, only a single medication from the serotonin-norepinephrine reuptake inhibitor class has evidence, and its benefit is also modest (PMID 32663120). Which medication to use and when to change or reduce it is decided with the prescribing physician. Long-lasting pain itself continues in What Is Chronic Pain? — A Microphone and an Amplifier, a Sound That Rings On Past Three Months.

The third focus is the feet. A foot with dulled sensation cannot signal injury through pain. Foot ulcers are present in 4 to 10 percent of people with diabetes, and the lifetime probability of developing one can reach 25 percent. These ulcers frequently become infected, and cases that end in leg amputation usually begin with such ulcers in their early stages (PMID 15644549). Ulcer prevention begins by identifying whether the protective sensation in the foot remains, and an examination using a thin nylon filament pressed against the sole of the foot is used in the clinic. A 2005 systematic review concluded that education teaching foot care to people with diabetes and regular foot examinations are effective interventions to prevent ulcers, while the effectiveness of prescription footwear was unclear (PMID 15644549).

While neuropathic pain medications have been confirmed to be superior to placebos, their magnitude is modest, and feet with dulled sensation due to diabetes are protected through education and regular foot examinations.

Signs to Check Quickly

After an infection like diarrhea or a sore throat, some people feel a tingling in their toes and, within a few days, find it hard to climb stairs as strength fades in both legs. If they recently had diarrhea or a respiratory infection, this disease becomes more likely (PMID 37814552). Guillain-Barré syndrome is a disease in which the immune system attacks the peripheral nerves, causing strength to rapidly drain from both arms and legs. It is a rare disease, infection precedes it in about three out of four cases, and a single bacterium that causes diarrhea accounts for about one-third of them (PMID 36430700).

The loss of strength usually moves up from below (PMID 39058828), and most patients recover, but about one-third need mechanical help to breathe, and 5% die (PMID 38813755). It is a dangerous yet treatable disease (PMID 38813755). Treatments with proven effectiveness are plasma exchange—filtering and replacing plasma—and intravenous immunoglobulin, which delivers immune proteins directly into a vein (PMID 25023340). The 2023 guidelines from the European Academy of Neurology (EAN) and the Peripheral Nerve Society (PNS) recommend giving immunoglobulin within 2 weeks of the onset of weakness, or plasma exchange within 4 weeks, for patients who cannot walk without help (PMID 37814552). There is a time window for treatment. Even with treatment, a significant number of patients are left with disabilities (PMID 33647239).

Besides Guillain-Barré syndrome, other types of numbness demand prompt attention. One should be even more cautious if numbness appears over a few days, spreads rapidly, is severe, concentrates on one side, starts near the trunk, or scatters across multiple areas. The same applies when weakness is pronounced or autonomic symptoms are severe. Such numbness can reveal Guillain-Barré syndrome or inflammation of blood vessels, so it must be handled quickly (PMID 37921132).

If numbness or weakness suddenly strikes one side of the face, arm, or leg alongside slurred speech, the location may be the brain rather than the peripheral nerves. A stroke is a disease in which blood supply to the brain is suddenly blocked or bursts, damaging the brain tissue that received that blood. Loss of strength in one arm and leg, speech disorders, sensory symptoms, and visual field defects belong to the symptoms of an ischemic stroke, which is caused by blocked blood flow. Even when these symptoms vanish within a day, the symptoms are generally the same, and they must be evaluated and treated as an emergency. Conditions unrelated to blood vessels can sometimes mimic the same symptoms, so they are sorted out through medical history, physical examination, and imaging tests (PMID 24157558). The meaning of those signs and time is covered in What a Stroke Actually Is — Blocked, Burst, and the Clock.

If lower back pain or leg numbness is accompanied by changes in urination or dulled sensation in the buttocks and groin, it is a strong signal to suspect cauda equina syndrome (PMID 38186331). Cauda equina syndrome is an emergency state where the bundle of nerve roots in the lower back and pelvis—which travel down below the end of the spinal cord—is compressed all at once, leading to simultaneous trouble with bowel and bladder control, leg sensation, and leg strength. If suspected, it must be checked urgently with an MRI, and once confirmed, surgery to relieve the compressed nerve roots is typically performed promptly. Delays in diagnosis or treatment can result in lifelong consequences, such as urinary and fecal incontinence or paralysis of the legs (PMID 42053010). Detailed stories continue in The Spinal Cord and Peripheral Nerves — A Trunk Line, and a Loop That Turns Back Halfway.

Checking what these signals mean is done through physical examinations and tests. Moreover, the most common cause of numbness in the tips of the hands and feet remains a single nerve compressed at a single site, the majority of which occur at the wrist (PMID 37921132).

Weakness moving upward from both legs over a few days, numbness or weakness suddenly striking one arm or leg, and urinary disturbances accompanying leg numbness are signs to be checked urgently without waiting.

Again, Numbness in the Toes

Let us return to the office worker from the beginning. It started in both toe tips together over several months, looked the same on both sides, and changed sensation first. It closely resembles the basic pattern of polyneuropathy that progresses slowly and follows length (PMID 32837227). In terms of supply lines, this is when the villages farthest away begin running short on household supplies.

In the clinic, after listening to the story and performing an exam, blood tests including blood sugar and vitamin B12 are done (PMID 41247746). Even if nerve conduction studies are normal, the small fibers may be injured (PMID 40002491). If diabetes is confirmed, managing blood sugar is the foundation, but in type 2, the benefit of preventing neuropathy from blood sugar control alone is small or nonexistent, so managing other coexisting conditions is placed alongside it (PMID 36115364). Even with careful evaluation, about half of polyneuropathies of this type initially remain of unknown cause, and a significant portion of those reveal a cause later (PMID 36997315).

If you lose sleep due to burning foot pain, neuropathic pain medication classes come up for discussion. They were better than a placebo, but for one more person to see an effect, roughly five to nearly nine people had to take them, and people stopping due to side effects also followed (PMID 40252663). If diabetes is confirmed and the sensation on the sole of the foot has become dull, regular foot exams and foot care education are used to prevent ulcers (PMID 15644549).

If the office worker's numbness spread within days rather than months and even leg strength gave way, the story changes. That is a sign to check hurriedly (PMID 37921132). Which tests to receive and which treatments to choose are matters to decide together with a doctor in the clinic.

Where to Look Next

How injured peripheral nerves grow back again is covered by How Peripheral Nerves Recover — An Introduction to Nerve Regeneration.

Diabetes, the most common cause of neuropathy, continues in What Is Diabetes? — The Letter That Never Comes, the Letter That Isn't Read; numbness and pain radiating from the lower back into the legs in What Is Low Back Pain? — Wrinkles in the Spine, Pain Without a Name; and stroke, which underlies sudden numbness on one side, in What a Stroke Actually Is — Blocked, Burst, and the Clock. Other diseases of the brain and nerves continue in "What Is Parkinson's Disease? — An Orchestra Whose Conductor Is Fading, a First Beat That Comes In Late", "Headache and Migraine — A Bell That Rings Easily, a Threshold That Falls as Attacks Grow Frequent", and "What Is Epilepsy? — Windows Lit One by One, Lights That Flash All at Once".

Source Papers

• "Peripheral Neuropathy: A Review." (2026) — PMID 41247746 — Peripheral neuropathy involves peripheral nerve damage, affects roughly 1% of adults, has over 200 causes, is length-dependent (starting from the longest axons in the toes toward the trunk), symmetrical, and more damaging to sensory axons, with diabetes as the most common cause (roughly 206 million people, over 50% of peripheral neuropathy in the West, autonomic symptoms like orthostatic hypotension), alongside genetics, medications (such as chemotherapy), alcohol, B12 deficiency, and monoclonal gammopathy, with up to 27% of unknown origin; initial tests include blood glucose, B12 and metabolites, and serum protein electrophoresis; three primary pain medication classes, with one $\alpha_2\delta$ drug showing a 50% or greater pain reduction in 38%; pain often persists, combination may offer added benefits, and prognosis depends on the cause, with complete recovery being rare.
• "Acroparesthesias: An Overview." (2024) — PMID 37921132 — Abnormal sensations in the hands and feet (numbness, tingling, prickling, reduced sensation) can arise anywhere along the sensory pathway from the peripheral nerves to the cerebral cortex; acute (over days), rapid progression, severity, asymmetry, proximal involvement, multi-focal distribution, motor predominance, and severe autonomic dysfunction warrant greater caution (prompt treatment for Guillain-Barré, vasculitis, etc.), and it is a representative symptom of polyneuropathy, frequently due to diabetes, with the single most common cause being mononeuropathy (primarily carpal tunnel syndrome).
• "Small fiber neuropathy." (2024) — PMID 39580213 — Neuropathy of small fibers (thinly myelinated A$\delta$ and unmyelinated C fibers), often presenting as burning neuropathic pain starting in the hands and feet and moving toward the trunk, along with autonomic dysfunction.
• "A Clinician's Approach to Peripheral Neuropathy." (2019) — PMID 31639835 — Starting with medical history (family history, occupation) and neurological examination; pattern recognition of acute/chronic, demyelinating/axonal, symmetrical/asymmetrical, sensory/motor, and autonomic symptoms; nerve conduction studies and electromyography serve as the main tools for large fiber polyneuropathy to distinguish axonal from demyelinating types; a demyelinating type greatly narrows the differential diagnosis and increases the likelihood of finding a treatable cause, making the identification of the cause important and often time-sensitive.
• "Diabetic peripheral neuropathy essentials: a narrative review." (2023) — PMID 36786097 — Diabetic peripheral neuropathy pain takes a "stocking and glove" pattern, with distal-to-proximal axonal loss.
• "Acute and chronic neuropathies." (2020) — PMID 32837227 — The basic pattern of polyneuropathy is chronic, length-dependent, sensory-motor axonopathy; departures from this basic pattern help identify the cause, and inflammatory conditions (such as Guillain-Barré) respond to effective immunotherapy.
• "New perspectives in diabetic neuropathy." (2023) — PMID 37263266 — Diabetic peripheral neuropathy is a length-dependent injury driven by metabolic and energy failure against the background of long axons and their supporting glial cells, underlying distal-to-proximal symptoms, with obesity and dyslipidemia also contributing, and no disease-modifying treatment available.
• "Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments." (2022) — PMID 36115364 — Affecting up to half of patients with diabetes, converging on energy failure due to the unique anatomy of peripheral nerves; glycemic control prevents it in type 1, but the benefit is small or absent in type 2 (likely due to comorbid conditions), and metabolic syndrome is a major risk factor.
• "Small-Fiber Neuropathy: An Etiology-Oriented Review." (2025) — PMID 40002491 — Small fiber neuropathy involves pain, temperature sensation changes, and autonomic dysfunction; standard tests for large fibers (nerve conduction studies and electromyography) are negative; diagnosis relies on skin biopsy or quantitative sensory testing when matching clinical findings, with unknown origin being the most common.
• "Advances in diagnosis and management of distal sensory polyneuropathies." (2023) — PMID 36997315 — Length-dependent, sensory-predominant, symmetrical chronic pain, tingling, and balance impairment; autonomic dysfunction and motor involvement depend on whether large or small fibers are primarily affected; despite thorough evaluation, roughly half initially have an unknown origin, though new symptoms and advances in testing often reveal the cause later.
• "Prevalence of peripheral neuropathy in patients with diabetes: A systematic review and meta-analysis." (2020) — PMID 31917119 — Across 29 studies and 50,112 people, peripheral neuropathy prevalence in patients with diabetes is 30%, with type 2 at 31.5% versus type 1 at 17.5%.
• "Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment." (2023) — PMID 38264279 — Present in 10% to 15% of newly diagnosed type 2 cases and exceeding 50% after more than 10 years of disease, prevalence increases with disease duration; hyperglycemia, lipid metabolism abnormalities, and insulin signaling defects serve as initiating factors, while the pathogenesis is not yet fully elucidated.
• "B Vitamin Deficiencies and Associated Neuropathies." (2026) — PMID 41609902 — B12 is essential for DNA synthesis, fatty acid metabolism, and myelin production; deficiency causes neuropathy and cognitive impairment, while B6 excess, rather than deficiency, is linked to neuropathy.
• "Vitamin B12 Deficiency: Common Questions and Answers." (2025) — PMID 40961307 — Affects roughly 2% to 3% of US adults, with risk factors including malabsorption, inadequate intake, certain medications, and older age, and symptoms including fatigue, brain fog, depression, peripheral neuropathy, and ataxia, with most cases correctable via oral supplementation.
• "Metformin-Induced Vitamin B12 Deficiency in Patients With Type-2 Diabetes Mellitus." (2023) — PMID 38034222 — Long-term use of the first-line oral medication for type 2 diabetes leads to reduced B12 absorption and deficiency.
• "Association between neuropathy and B-vitamins: A systematic review and meta-analysis." (2021) — PMID 33619867 — Peripheral neuropathy is linked to low B12, high methylmalonic acid, and homocysteine, while the link between B12 treatment and symptom improvement is not significant across 4 studies; authors' conclusion: B vitamins may suggest symptom improvement, but trials have limitations and generally do not assess baseline vitamin status.
• "Alcohol-related peripheral neuropathy: a systematic review and meta-analysis." (2019) — PMID 30467601 — Nerve conduction study-confirmed peripheral neuropathy is present in 46.3% of chronic heavy drinkers, presenting as sensory-predominant, length-dependent axonal type, with total lifetime alcohol intake as the most important risk factor and unknown mechanism.
• "Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: An update." (2022) — PMID 35104697 — Symptoms are sensory rather than motor (reduced sensation, hypersensitivity to pressure, pain, temperature, and touch).
• "Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis." (2014) — PMID 25261162 — Across 31 studies and 4,179 people, rates are 68.1% in the first month after chemotherapy, 60.0% at 3 months, and 30.0% at 6 months or later.
• "Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update." (2020) — PMID 32663120 — No drugs are recommended for prevention; clinicians should evaluate the appropriateness of delaying, reducing, switching, or stopping chemotherapy in cases of intolerable neuropathy or functional impairment; for established painful chemotherapy-induced peripheral neuropathy, only one SNRI drug has supporting evidence, and its benefit is limited.
• "Pitfalls in electrodiagnosis." (1999) — PMID 10653302 — The purpose of electromyography is to distinguish whether weakness is neurogenic or myopathic, conduction studies examine only large myelinated fibers, and results must always be interpreted in a clinical context.
• "Carpal tunnel syndrome." (2008) — PMID 18269111 — Nighttime pain, tingling, and numbness in the median nerve distribution are classic symptoms, and nerve conduction studies are standard, though false positives and false negatives occur.
• "Carpal tunnel syndrome." (2024) — PMID 38697747 — The most common entrapment neuropathy, with risk factors including female sex, obesity, occupation, hypothyroidism, and pregnancy; diagnosed clinically, supported by electrodiagnostic testing, though some cases test normal.
• "Carpal Tunnel Syndrome: Diagnosis and Management." (2016) — PMID 28075090 — Affecting the palmar side of the thumb, index, middle, and radial half of the ring finger; mild or moderate cases receive conservative treatment (splints, steroids, physical therapy, etc.); nonsteroidal anti-inflammatory drugs, diuretics, and vitamin B6 show no efficacy; local steroid injection provides relief for over a month and delays the need for surgery at the 1-year mark; severe cases or those failing to improve after 4 to 6 months of conservative treatment require surgery.
• "Carpal tunnel sonography." (2020) — PMID 32323256 — Occurs in 1 to 3 per 1,000 people annually, aged 45 to 60, more common in women; electrophysiological testing helps rule out other causes such as cervical radiculopathy and polyneuropathy.
• "Diagnostic Test Accuracy of Provocative Maneuvers for the Diagnosis of Carpal Tunnel Syndrome: A Systematic Review and Meta-Analysis." (2023) — PMID 37366626 — Phalen's test has a sensitivity of 0.57 and specificity of 0.67, while Tinel's sign has a sensitivity of 0.45 and specificity of 0.78; the meta-analysis shows imprecision, leading the authors to conclude that one should not rely on a single physical maneuver and instead combine multiple tests.
• "Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy." (2021) — PMID 34050323 — No universally accepted disease-modifying treatment exists; a multidisciplinary approach is used to prevent foot complications.
• "Diabetic neuropathies." (2014) — PMID 25299279 — Early diagnosis and improved blood glucose management are slowing progression (as of 2014), and small fiber or asymptomatic stages can be reversed or significantly improved with appropriate intervention.
• "Evolving Treatment Strategies for Neuropathic Pain: A Narrative Review." (2025) — PMID 40572751 — Neuropathic pain commonly presents as burning, stabbing, tingling, or electric shock-like sensations.
• "Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysis." (2025) — PMID 40252663 — NeuPSIG reviewed 313 placebo-controlled randomized trials involving 48,789 adults, finding number needed to treat (NNT) values of 4.6 for tricyclics, 7.4 for SNRIs, and 8.9 for $\alpha_2\delta$ drugs, with number needed to harm (NNH) values for discontinuation due to adverse events of 17.1, 13.9, and 26.2, strongly recommending the three classes as first-line options; authors' conclusion: treatment outcomes are modest and some uncertainty remains.
• "Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis." (2015) — PMID 25575710 — Across 229 studies, publication bias may have overestimated treatment effects by roughly 10%, and trial results are generally modest.
• "Preventing foot ulcers in patients with diabetes." (2005) — PMID 15644549 — Foot ulcers affect 4% to 10% of patients with diabetes, with a lifetime occurrence up to 25%, frequently leading to infection and serving as the first step toward lower extremity amputation; screening starts with loss of protective sensation (monofilament testing), and foot care education and regular foot exams are effective, while the value of prescription footwear remains unclear.
• "European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome." (2023) — PMID 37814552 — A recent history of diarrhea or respiratory infection increases probability; intravenous immunoglobulin within 2 weeks or plasma exchange within 4 weeks is recommended for patients unable to walk unaided.
• "Triggers of Guillain-Barré Syndrome: Campylobacter jejuni Predominates." (2022) — PMID 36430700 — A rare immune-mediated acute polyradiculoneuropathy preceded by an infection in three-quarters of cases, with Campylobacter jejuni accounting for roughly one-third.
• "Clinical presentation and symptomatology of Guillain-Barré syndrome: A literature review." (2024) — PMID 39058828 — Acute onset of ascending paralysis and sensory disturbances.
• "Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis." (2014) — PMID 25023340 — Rapidly progressive symmetrical limb weakness, autonomic dysfunction in many patients, mostly diagnosed clinically and supported by lumbar puncture and electrophysiological testing, with intravenous immunoglobulin and plasma exchange established as effective treatments.
• "Guillain-Barré syndrome: a comprehensive review." (2024) — PMID 38813755 — A dangerous but treatable condition; most recover, though roughly one-third require mechanical ventilation and 5% die.
• "Guillain-Barré syndrome." (2021) — PMID 33647239 — Most do well with immunotherapy, but a significant number are left with disability, and mortality occurs.
• "Symptoms of transient ischemic attack." (2014) — PMID 24157558 — Symptoms of a transient ischemic attack (lasting less than 24 hours) are largely the same as an ischemic stroke (weakness in one side of the limbs, speech disturbances, sensory symptoms, visual field defects, gait difficulties), mimicking non-vascular conditions as well, thus requiring differentiation via medical history, examination, and imaging, along with emergency evaluation and treatment.
• "Cauda equina syndrome." (2023) — PMID 38186331 — Red flag signs such as bladder dysfunction, saddle anesthesia, and sciatica strongly suggest cauda equina syndrome, requiring MRI within 1 hour of emergency department arrival, and generally recommending urgent decompressive surgery.
• "Cauda Equina Syndrome-A 2025 Narrative Review." (2026) — PMID 42053010 — A surgical emergency resulting from acute compression of lumbosacral nerve roots, diagnosed via physical examination and emergency MRI, and once confirmed, typically treated with urgent decompressive surgery within 24 hours, where diagnostic and treatment delays lead to lifelong consequences such as bowel and urinary incontinence, sexual dysfunction, lower limb paralysis, and chronic pain.